Skip to main content

Advertisement

Table 2 Types of insulin therapy according to geographic region

From: Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group

  Insulin Monotherapy *   
Type of insulin monotherapy Southeast South Northeast/North Mid-west
NPH 152 (96.8) 41 (83.7) 275 (94.5) 54 (87.1)
Glargine or Detemir 5 (3.2) 8 (16.3) 16 (5.5) 8 (12.9)
  Combined Insulin Therapy**   
Type of combination of insulin therapy Southeast South Northeast/North Mid-west
NPH plus Regular 573 (46.2) 357 (46.9) 677 (82.7) 79 (47.0)
NPH plus Lispro 271 (21.8) 194 (25.5) 12 (1.5) 11 (6.5)
NPH plus Aspart 91 (7.3) 38 (5.0) 13 (1.6) 4 (2.4)
NPH plus Glulisine 6 (0.5) 4 (0.5) 7 (0.9) 5 (3)
Glargine plus regular 16 (1.3) 12 (1.6) 10 (1.2) 1 (0.6)
Glargine plus Lispro 158 (12.7) 71 (9.3) 25 (3.1) 48 (28.6)
Glargine plus Aspart 57 (4.6) 67 (8.8) 32 (3.9) 6 (3.6)
Glargine plus Glulisine 2 (0.2) 3 (0.4) 3 (0.4) 13 (7.7)
Detemir plus regular 4 (0.3) - 5 (0.6) -
Detemir plus Lispro 25 (2) 3 (0.4) 9 (1.1) 1 (0.6)
Detemir plus Aspart 37 (3) 12 (1.6) 24 (2.9) -
Detemir plus Glulisine 1 (0.1) - 2 (0.2) -
  1. The data are presented as n (%); * /** p<0.001 for comparisons among the groups.